Drug Shortage Report for JAMP-METHOTREXATE
| Report ID | 137048 |
| Drug Identification Number | 02419173 |
| Brand name | JAMP-METHOTREXATE |
| Common or Proper name | Methotrexate |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METHOTREXATE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS |
| Packaging size | 5x2mL |
| ATC code | L01BA |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-12-01 |
| Estimated end date | 2023-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-10-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-10-07 | French | Compare |
| v3 | 2022-10-07 | English | Compare |
| v2 | 2021-04-07 | French | Compare |
| v1 | 2021-04-07 | English | Compare |
Showing 1 to 4 of 4